You are on page 1of 4


In most cases, fibrodysplasia ossificans progressiva starts in early infancy with episodes of soft
tissue swelling; however, reports exist of in utero involvement.
Ectopic bone formation is usually first evident in early childhood in children aged 2-6 years. The
main target is the axial musculature, but eventually ectopic bone formation occurs in the
ligaments, the fascia, the aponeuroses, the tendons, and the joint capsules. Involvement often
demonstrates a proximal-to-distal predilection.
Most patients become bedridden by time they are in their 30s.
Chronic neurological symptoms are common in these patients.[13] These findings include
neuropathic pain, especially in females (15%). Many had other sensory abnormalities.
Fibrodysplasia ossificans progressiva lesions are characterized by painful, tender, rubbery, soft
tissue indurations, usually precipitated by a trauma. Lesions mainly develop in the paraspinal
muscles of the back and in the limb girdles. Some of the tumors undergo ossification, which can
also affect the tendons, the ligaments, and the fascia.
Characteristics of diagnostic value are a hallus valgus deformity (present at birth), torticollis (due
to involvement of the sternocleidomastoid muscle), joint immobilization (due to periarticular
ossificans), and a thorax deformity (both lateral and anteroposterior).
Fibrodysplasia ossificans progressiva limited to the maxillofacial region has been described. [14] It
may produce a fusion between the mandibular ramus and the zygomatic complex and trismus.
All proximal tibial osteochondromas are a common phenotypic feature. [15, 16]Mobility is restricted
because of ankylosis of the spine and the rib cage.
Fibrodysplasia ossificans progressiva is sometimes associated with alopecia and deafness.[17]
Aslan et al reported ankylosis of the jaw and van der Meij et al reported restricted mandibular
movement, both associated with fibrodysplasia ossificans progressiva.[18, 19]
Note the images below.

Widespread tumors and indurations mainly in the scapular area, found










Typical hallus valgus deformity.

Fibrodysplasia ossificans progressiva is an idiopathic condition precipitated by trauma.
The pathophysiology of fibrodysplasia ossificans progressiva is unknown. It is an inherited
autosomal dominant disorder with complete penetration but variable gene expressivity. Findings
suggest that fibrodysplasia ossificans progressiva maps to band 4q27-31, a region that contains at
least 1 gene involved in the bone morphogenic protein (BMP) signaling pathway.[1] BMPs are
members of the transforming growth factor-beta superfamily and play a role in the development
of bone and other tissues.[2] The condition is multifocal, starting to develop usually after
traumatization. The genetic cause of fibrodysplasia ossificans progressiva lies within
the ACVR1 gene, which encodes a type I BMP transmembrane receptor. A recurrent mutation in
the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans
progressiva.[3] In one study, it was mapped to 2q23-24 by linkage analysis.[4]

A number of mutations have been documented. A mutation of the noggin (NOG) gene in a
fibrodysplasia ossificans progressiva family has been described. [5] TheFOP gene in the 17q21-22
region had been observed with several mutations described in the NOG gene (located in 17q22)
in 4 fibrodysplasia ossificans progressiva patients, including the G91C mutation, which was
transmitted dominantly in a Spanish fibrodysplasia ossificans progressiva family. This mutation
is a guanine to adenine change at nucleotide 283 (283G>A) of the NOGgene and was
transmitted by the affected mother to her 2 affected children. A novel mutation in the activin A
type 1 receptor gene was described in one patient.[6] Analysis showed that the patient was
heterozygous for a mutation, G356D.[7]
Patients with fibrodysplasia ossificans progressivalike heterotopic ossification and/or toe
malformations have been described in 2 categories: fibrodysplasia ossificans progressivaplus
(classic defining features of fibrodysplasia ossificans progressiva plus one or more atypical
features) and fibrodysplasia ossificans progressiva variants (major variations in one or both of
the 2 classic defining features of fibrodysplasia ossificans progressiva) [8] While the typical
mutation was found in all cases of classic fibrodysplasia ossificans progressiva and most cases of
fibrodysplasia ossificans progressivaplus, novel ACVR1 mutations were identified in the
fibrodysplasia ossificans progressiva variants and some with fibrodysplasia ossificans
Two unique mutations in the ACVR1 gene have also been identified in 2 fibrodysplasia ossificans
progressiva patients from the United Kingdom with some atypical digit abnormalities and other
clinical features[9] . A patient from Japan with an ACVR1 gene mutation had normal development
until age 17 years and a mild clinical course. [10] The resultant mutations were interpreted to result
in local structural changes in the ACVR1 protein, as revealed by interrogating homology models
of the native and mutated ACVR1 kinase domains.
Impaired binding to FKBP1A and an altered subcellular distribution by R206H ACVR1 mutation
may activate osteogenic BMP-signaling in extraskeletal sites, leading to delayed and progressive
ectopic bone formation.[11]

A novel ALK2 mutation, L196P, was identified in a mild form of fibrodysplasia ossificans